XML 115 R100.htm IDEA: XBRL DOCUMENT v3.25.1
Business Segments (Information on Operating and Reportable Segments) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Feb. 28, 2023
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Segment Reporting Information, Profit (Loss):        
Total segment revenues   $ 1,137,762 $ 1,125,357 $ 1,127,725
Cost of sales   503,299 500,909 502,431
Gross profit   634,463 624,448 625,294
Advertising and marketing   155,723 153,315 145,061
Contribution margin   478,740 471,133 480,233
Other operating expenses   141,965 128,704 502,648
Operating income (loss)   336,775 342,429 (22,415)
Impairment of intangible assets   12,466   321,400
Goodwill, impairment loss $ 48,800     $ 48,800
Impairment, Intangible Asset, Statement Of Income Or Comprehensive Income, Extensible Enumeration, Not Disclosed Flag       Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)
North American OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total segment revenues   960,010 958,260 $ 973,774
North American OTC Healthcare | Operating Segments        
Segment Reporting Information, Profit (Loss):        
Total segment revenues   960,010 958,260 973,774
Cost of sales   428,871 429,361 441,844
Gross profit   531,139 528,899 531,930
Advertising and marketing   129,431 131,494 123,926
Contribution margin   401,708 397,405 408,004
North American OTC Healthcare | Intersegment Eliminations        
Segment Reporting Information, Profit (Loss):        
Total segment revenues   3,900 3,700 4,300
International OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total segment revenues   177,752 167,097 153,951
International OTC Healthcare | Operating Segments        
Segment Reporting Information, Profit (Loss):        
Total segment revenues   177,752 167,097 153,951
Cost of sales   74,428 71,548 60,587
Gross profit   103,324 95,549 93,364
Advertising and marketing   26,292 21,821 21,135
Contribution margin   $ 77,032 $ 73,728 $ 72,229